Hospital Groups Outraged at Boehringer Ingelheim, Company Defends Its Plans and Calls for 340B Overhaul
Hospital trade group 340B Health has asked pharmaceutical giant Boehringer Ingelheim (BI) to withdraw its plan to cut off discounts for drugs that are distributed by contract pharmacies. As 340B Report broke on July 1, BI will stop shipping 340B-purchased drugs to hospitals’ contract pharmacies, effective Aug. 1.